TrialArthritis & rheumatology (Hoboken, N.J.)2021

Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study.

W Winn Chatham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.